Get started
Author

Rainer von Coelln

Observed names: Coelln, Rainer V., R von Coelln, R. Von Coelln, R. von Coelln, R.V. Coelln, Rainer Coelln, Rainer V. Coelln, Rainer Von Coelln, Ranier von Coelln, Von Coelln, Rainer
Observed institutions: University of Maryland, Baltimore, University of Maryland Medical Center, Johns Hopkins University, Baylor College of Medicine, Heidelberg University, Johns Hopkins Medicine, German Center for Neurodegenerative Diseases, Universitätsklinikum Tübingen, Hertie Institute for Clinical Brain Research, Texas Children's Hospital, University of Maryland School of Medicine, University of Cincinnati, University of Maryland, College Park, University of Tübingen
ORCID: 0000-0001-7651-2780
Observed ORCID: 0000-0001-7651-2780
OpenAlex ID: A5073765508
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
2019 · Mike A Nalls, Cornelis Blauwendraat, et al. · The Lancet Neurology · 2,434
PDF
Loss of locus coeruleus neurons and reduced startle in parkin null mice
2004 · Rainer von Coelln, Bobby Thomas, et al. · Proceedings of the National Academy of Sciences · 347
PDF
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
2019 · Cornelis Blauwendraat, Karl Heilbron, et al. · Movement Disorders · 338
PDF
Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death
2005 · Han Seok Ko, Rainer von Coelln, et al. · Journal of Neuroscience · 247
PDF
Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
2000 · Olaf Eberhardt, Rainer V. Coelln, et al. · Journal of Neuroscience · 209
PDF
Parkin-associated Parkinson’s disease
2004 · Rainer von Coelln, Valina L. Dawson, et al. · Cell and Tissue Research · 132
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia
1998 · Jörg B Schulz, Michael Weller, et al. · Cell Death and Differentiation · 96
Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals
2001 · Rainer von Coelln, Sebastian Kügler, et al. · Journal of Neurochemistry · 95
Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy
2006 · Rainer von Coelln, Bobby Thomas, et al. · Journal of Neuroscience · 91
PDF
Ultrasound‐guided injection of the iliopsoas muscle with botulinum toxin in camptocormia
2008 · Rainer von Coelln, Armin Raible, et al. · Movement Disorders · 88
Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease
2016 · Rainer von Coelln, Lisa M. Shulman · Current Opinion in Neurology · 72
MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
2007 · Bobby Thomas, Rainer von Coelln, et al. · Neurobiology of Disease · 68
The inconsistency and instability of Parkinson's disease motor subtypes
2021 · R. von Coelln, A.L. Gruber-Baldini, et al. · Parkinsonism & Related Disorders · 51
Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
2021 · Isabel Alfradique-Dunham, Rami Al-Ouran, et al. · Neurology Genetics · 42
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity
2021 · Emily J. Hill, C. Grant Mangleburg, et al. · Parkinsonism & Related Disorders · 38
PDF
Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networks
2020 · Sanjukta Krishnagopal, Rainer von Coelln, et al. · PLoS ONE · 33
PDF
Quantitative mobility metrics from a wearable sensor predict incident parkinsonism in older adults
2019 · Rainer von Coelln, Robert J. Dawe, et al. · Parkinsonism & Related Disorders · 32
Screening of interleukins for survival-promoting effects on cultured mesencephalic dopaminergic neurons from embryonic rat brain
1995 · Rainer von Coelln, Klaus Unsicker, et al. · Developmental Brain Research · 32
Parkinson's Disease: Patients’ Knowledge, Attitudes, and Interest in Genetic Counseling
2018 · Kristin A. Maloney, Dina S. Alaeddin, et al. · Journal of Genetic Counseling · 26
Weight loss and weight gain in Parkinson disease
2021 · Shadi Ghourchian, Ann L. Gruber-Baldini, et al. · Parkinsonism & Related Disorders · 22
Genome Sequencing in the Parkinson Disease Clinic
2022 · Emily J. Hill, Laurie A. Robak, et al. · Neurology Genetics · 18
PDF
Migratory stroke-like lesions in a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and a review of imaging findings
2016 · Stephen S. Cai, Rainer von Coelln, et al. · Radiology Case Reports · 15
PDF
Cerebral low-grade lymphoma and light chain deposition disease: exceedingly high IgG levels in the cerebrospinal fluid as a diagnostic clue
2010 · G. Pantazis, T. Psaras, et al. · Clinical Neuropathology · 15
Applying Wearable Sensors and Machine Learning to the Diagnostic Challenge of Distinguishing Parkinson’s Disease from Other Forms of Parkinsonism
2025 · Rana M. Khalil, Lisa M. Shulman, et al. · Biomedicines · 12
Response shift – The experience of disease progression in Parkinson disease
2016 · Jessica Yang, Brenda Hanna-Pladdy, et al. · Parkinsonism & Related Disorders · 12
Works count: 55
Citation count: 7,052
H-index: 21
I10-index: 28
Year
Topic
Type